Michael Mussallem - Edwards Lifesciences Insider

EW -- USA Stock  

USD 153.90  0.30  0.20%

Chairman and CEO

Mr. Michael A. Mussallem is Chairman of the Board, Chief Executive Officer of the Company. He has an extensive knowledge of the medical technology industry in general, and of the people, operations, processes and products of the Company, in particular, built over a 35year career with the Company and its predecessor. In addition, in his roles with AdvaMed and other healthcarerelated organizations, he has become a recognized leader in the medical technology industry, making important contributions to healthcare policy discussions in California, the United States and the key global markets that the Company serves. These experiences have established relationships which are helpful in developing the Board strategic perspective and enhanced his leadership of the Company and contributions to the Board. He received his BS in Chemical Engineering and an honorary doctoral degree from the Rose Hulman Institute of Technology
Age: 63  Chairman Since 2000  Ph.D    
949-250-2500  http://www.edwards.com

Michael Mussallem Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 11.51 % which means that for every $100 of asset it generated profit of $11.51. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 18.7 % which means that it produced $18.7 on every 100 dollars invested by current stockholders.
The company reports 1.05 B of total liabilities with total debt to equity ratio (D/E) of 32.4 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 2.03 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Entity Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and traded on New York Stock Exchange. It employs 12200 people.Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 12,200 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Edwards Lifesciences Leadership Team

John Cardis, Director
Wesley Schack, Director, MBA
Larry Wood, VP, MBA
Nicholas Valeriani, Director, MBA
Leslie Heisz, Director, MBA
Catherine Szyman, President, MBA
Martha Marsh, Director, MBA
Huimin Wang, President, MBA
Barbara McNeil, Director, Ph.D
Steven Loranger, Director
William Link, Director
Scott Ullem, CFO, MBA
Patrick Verguet, VP, Ph.D
Kieran Gallahue, Director, MBA
Bernard Zovighian, President, MBA
David Erickson, President
Donald Bobo, VP
Michael Mussallem, Chairman, Ph.D

Stock Performance Indicators

Did you try this?

Run Alpha Finder Now

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Alpha Finder

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Edwards Lifesciences and Express Scripts Holding. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.